VERRICA PHARMACEUTICALS INC
COM · CUSIP 92511W108
0
institutional holders
-2 vs Q3 2025
—reported value*
0 new
0 added
0 reduced
2 sold out
net sold ≈ $301 (-596 shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 50 |
| Q4 2022 | 51 |
| Q1 2023 | 61 |
| Q2 2023 | 64 |
| Q3 2023 | 68 |
| Q4 2023 | 65 |
| Q1 2024 | 63 |
| Q2 2024 | 75 |
| Q3 2024 | 80 |
| Q4 2024 | 82 |
| Q1 2025 | 76 |
| Q2 2025 | 55 |
| Q3 2025 | 2 |
| Q4 2025 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2024 | 19 | 30 |
| Q2 2024 | 37 | 26 |
| Q3 2024 | 41 | 29 |
| Q4 2024 | 38 | 35 |
| Q1 2025 | 38 | 25 |
| Q2 2025 | 24 | 53 |
| Q3 2025 | 0 | 53 |
| Q4 2025 | 0 | 2 |
Biggest buyers
| None |
Biggest sellers
| OSAIC HOLDINGS, INC. | Sold out | -568 |
| CWM, LLC | Sold out | -28 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| ARMISTICE CAPITAL, LLC 13G · institution no change · filed 2025-08-14 | 10.0% |
| Caligan Partners LP 13G · institution new · filed 2025-02-12 | 10.0% |
Holders, Q4 2025
| Manager | Shares | Change |
|---|